David D. Thiel

ORCID: 0000-0002-5926-3636
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal cell carcinoma treatment
  • Renal and Vascular Pathologies
  • Pediatric Urology and Nephrology Studies
  • Urological Disorders and Treatments
  • Bladder and Urothelial Cancer Treatments
  • Surgical Simulation and Training
  • Prostate Cancer Diagnosis and Treatment
  • Urinary Bladder and Prostate Research
  • Ureteral procedures and complications
  • Renal and related cancers
  • Organ Donation and Transplantation
  • Pelvic floor disorders treatments
  • Minimally Invasive Surgical Techniques
  • Urologic and reproductive health conditions
  • Kidney Stones and Urolithiasis Treatments
  • Urinary and Genital Oncology Studies
  • Anatomy and Medical Technology
  • Advanced X-ray and CT Imaging
  • Cancer Genomics and Diagnostics
  • Radiation Dose and Imaging
  • Cardiac, Anesthesia and Surgical Outcomes
  • MRI in cancer diagnosis
  • Anorectal Disease Treatments and Outcomes
  • Diverticular Disease and Complications
  • Pancreatic and Hepatic Oncology Research

Jacksonville College
2016-2025

Mayo Clinic in Florida
2016-2025

WinnMed
2015-2025

ATUM (United States)
2023

Menlo School
2023

Collaborative Research Group
2022

Nemours Children’s Clinic
2021

Mayo Clinic Hospital
2020

Nemours Children's Clinic
2005-2020

Jacksonville University
2011-2019

M.C. Liu Geoffrey R. Oxnard Eric A. Klein Charles Swanton Michael V. Seiden and 95 more Minetta C. Liu Geoffrey R. Oxnard Eric A. Klein David A. Smith Donald Richards Timothy J. Yeatman Allen Lee Cohn Rosanna L. Lapham Jessica Clément Alexander S. Parker Mohan K. Tummala Kristi McIntyre Mikkael A. Sekeres Alan H. Bryce Robert D. Siegel Xuezhong Wang David Cosgrove Nadeem R. Abu‐Rustum Jonathan C. Trent David D. Thiel Carlos Becerra Manish Agrawal Lawrence Garbo Jeffrey K. Giguere Ross M. Michels Ronald P. Harris Stephen Richey Timothy A. McCarthy David Waterhouse Fergus J. Couch Sharon Wilks Amy Krie Rama Balaraman Alvaro Restrepo Michael Meshad Kimberly Rieger‐Christ Travis Sullivan Christine Lee Daniel Greenwald William Oh Che‐Kai Tsao Neil Fleshner Hagen F. Kennecke Maged Khalil David R. Spigel Atisha Manhas Brian Ulrich P. Kovoor Christopher Stokoe Jay Courtright Habte A. Yimer Timothy Larson Charles Swanton Michael V. Seiden Steven R. Cummings Farnaz Absalan Gregory E. Alexander Brian C. Allen Hamed Amini Alexander M. Aravanis Siddhartha Bagaria Leila Bazargan John F. Beausang Jennifer R. Berman Craig Betts Alexander W. Blocker Joerg Bredno Robert Calef Gordon Cann Jeremy G. Carter Christopher Chang Hemanshi Chawla Xiaoji Chen Tom C. Chien Daniel Civello Konstantin Davydov Vasiliki Demas Mohini Jangi Dong Zhao Saniya Fayzullina Alexander P. Fields Darya Filippova Peter Freese Eric T. Fung Sante Gnerre Samuel Gross Meredith Halks‐Miller Megan P. Hall Anne‐Renee Hartman Chenlu Hou Earl Hubbell Nathan Hunkapiller Karthik A. Jagadeesh Arash Jamshidi Roger Jiang

Early cancer detection could identify tumors at a time when outcomes are superior and treatment is less morbid. This prospective case-control sub-study (from NCT02889978 NCT03085888) assessed the performance of targeted methylation analysis circulating cell-free DNA (cfDNA) to detect localize multiple types across all stages high specificity.

10.1016/j.annonc.2020.02.011 article EN cc-by-nc-nd Annals of Oncology 2020-03-30

In the Circulating Cell-free Genome Atlas (NCT02889978) substudy 1, we evaluate several approaches for a circulating cell-free DNA (cfDNA)-based multi-cancer early detection (MCED) test by defining clinical limit of (LOD) based on tumor allele fraction (cTAF), enabling performance comparisons. Among 10 machine-learning classifiers trained same samples and independently validated, when evaluated at 98% specificity, those using whole-genome (WG) methylation, single nucleotide variants with...

10.1016/j.ccell.2022.10.022 article EN cc-by-nc-nd Cancer Cell 2022-11-17

Planning complex operations such as robotic-assisted partial nephrectomy requires surgeons to review 2-dimensional computed tomography or magnetic resonance images understand 3-dimensional (3-D), patient-specific anatomy.To determine surgical outcomes for when reviewed 3-D virtual reality (VR) models during operative planning.A single-blind randomized clinical trial was performed. Ninety-two patients undergoing performed by 1 of 11 at 6 large teaching hospitals were prospectively enrolled...

10.1001/jamanetworkopen.2019.11598 article EN cc-by-nc-nd JAMA Network Open 2019-09-18

Immune checkpoint inhibitors (ICI) are revolutionizing care for cancer patients. The list of malignancies which the Food and Drug Administration is granting approval rapidly increasing. Furthermore, there a concomitant increase in clinical trials incorporating ICI. However, safety ICI patients undergoing surgery remains unclear. Herein, we assessed perioperative setting at single center. We conducted retrospective review who underwent planned while receiving from 2012 to 2016. collected...

10.3389/fonc.2017.00121 article EN cc-by Frontiers in Oncology 2017-06-12

Purpose: Planning for robotic-assisted partial nephrectomy requires surgeons to review two-dimensional CT or MRI scans understand three-dimensional (3D) anatomy. We sought determine the drivers of improvements in key surgical outcomes when using patient-specific 3D virtual reality (VR) models operative planning. Materials and Methods: A multicenter, randomized, single-blind clinical trial was conducted from January 2019 December 2020. Patients undergoing were randomly assigned a control...

10.1097/ju9.0000000000000101 article EN cc-by-nc-nd JU Open Plus 2024-01-01

Dual-energy computed tomography (DECT) is an emerging imaging modality with the unique capability of determining urinary stone composition. This study compares radiation exposure DECT, standard single-energy CT (SECT), and low-dose renal protocol (LDSECT) for evaluation nephrolithiasis in a single vivo patient cohort.Following institutional review board (IRB) approval, we retrospectively reviewed 200 consecutive DECT examinations performed on patients suspected urolithiasis over 6-month...

10.1089/end.2014.0026 article EN Journal of Endourology 2014-07-24

INTRODUCTION: Robotic surgical technology has evolved to include a new platform specifically designed for the single-port (SP) approach. Benefits of da Vinci SP are still under investigation. This study aimed review urological literature since first report use platform.EVIDENCE ACQUISITION: We performed systematic PubMed, Medline, and Web Science databases on June 15, 2020 searching all available articles from December 2014 (date clinical in urology) until 1, following Preferred Reporting...

10.23736/s2724-6051.20.03899-0 article EN Minerva Urology and Nephrology 2021-03-01

Venous thromboembolism (VTE) after urologic surgery occurs in about 1% of patients and is associated with peri-operative morbidity mortality. Given variability thromboprophylaxis practice, we aim to analyze the utilization Caprini risk-based prostatectomy nephrectomy. Cases were identified using medical record from large tertiary care centers United States. score was calculated retrospectively. Prophylaxis classified as either appropriate or inappropriate when comparing recommendations...

10.1097/upj.0000000000000781 article EN Urology Practice 2025-02-04

Abstract The mechanisms underlying metastatic latency in renal cell carcinoma (RCC) remain poorly understood. This study evaluated two large independent cohorts for differences tumor biology between patients who developed metastases early (≤1 year after nephrectomy) and those with late-onset (>3 years). In the discovery cohort (n = 161), late-metastatic RCC (late-mRCC) was associated clear histology (88.9% vs 78.7%), lower pathological stage (pT1-2; 40.3% 18.0%), favorable...

10.1093/jnci/djaf060 article EN JNCI Journal of the National Cancer Institute 2025-03-11

To analyze and compare the safety peri-operative outcomes of fellowship-trained robotic surgeons (FEL) experienced open (OE) incorporating robot-assisted laparoscopic prostatectomy (RALP) into practice.Multiinstitutional, prospective data were collected on first 30 RALP performed by FEL OE (defined as over 1000 prostatectomies) practice. Morbidity from course was evaluated operative outcomes. The second cases group to assess for improvement with experience.There no rectal injuries or death...

10.1089/end.2009.0657 article EN Journal of Endourology 2010-09-18

Abstract Background Cancer‐specific anxiety (CSA) can affect treatment decisions and is common in men following surgery for prostate cancer (PCa). We hypothesized that CSA also associated with factors affecting quality of life. Herein, we examine the association psychosocial PCa aggressiveness a cohort 1 year after prostatectomy localized PCa. Methods From our prospective Registry, identified 365 who underwent completed Memorial Anxiety Scale Prostate Cancer (MAX‐PC) Expanded Index Composite...

10.1002/pon.3138 article EN Psycho-Oncology 2012-08-01

A current dilemma is how to incorporate robot assisted laparoscopic radical prostatectomy (RALP) into residency/fellowship programs while containing costs and maintaining acceptable operative times. We prospectively analyzed factors that affect the time of nine separate RALP steps performed in a training program incorporating da Vinci robot.A prospective evaluation 50 consecutive by single surgeon trainees was completed. divided segments, each segment recorded minutes. Who portion procedure...

10.1089/end.2008.0023 article EN Journal of Endourology 2008-05-16

It remains unclear whether the hemodilution effect of body mass index (BMI) on PSA levels translates to inappropriate prostate cancer (PCa) screening in obese men. To address this, we conducted two nested case–control studies within prospective cohorts men undergoing radical prostatectomy for newly diagnosed PCa. We identified 1817 with BMI ⩾30 kg m−2 (cases) and 1244 <25 (controls) who underwent surgery treat PCa at Mayo Clinic Rochester between 2000 2009. Cases controls were frequency...

10.1038/pcan.2013.27 article EN cc-by-nc-nd Prostate Cancer and Prostatic Diseases 2013-08-20
Coming Soon ...